<DOC>
	<DOC>NCT02795975</DOC>
	<brief_summary>The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.</brief_summary>
	<brief_title>Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples</brief_title>
	<detailed_description />
	<mesh_term>Gonorrhea</mesh_term>
	<criteria>The subject is ≥14 years of age at the time of enrollment and is currently sexually active (eg, has had penile/vaginal intercourse within the past 6 months). For subjects under 18 years old, assent of the subject and/or parental/legal guardian permission has been obtained if required by the institutional review board (IRB). The subject and/or legally authorized representative is willing and able to undergo the informed consent process prior to study participation, and: reports symptoms consistent with a suspected STI (eg, abnormal discharge, genital itching, pain/discomfort during sexual intercourse or urination, and/or lower abdominal discomfort); or is asymptomatic and known to be partners with, or a contact of, a person with a confirmed or suspected STI; or is asymptomatic and undergoing screening evaluation for possible STIs; or is asymptomatic and undergoing a routine pelvic examination. The subject took antibiotic medications within the last 21 days prior to collection. The subject already participated in the study. The subject has a history of illness that the PI or designee considers could interfere with or affect the conduct, results, and/or completion of the study.</criteria>
	<gender>Female</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>